Sophia Hober
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Integrating Tumor Targeting and Half-Life Extension into a Dual-Surfaced Single-Domain ADAPT Protein.
Journal: Molecular pharmaceutics
Published: May 14, 2026
Engineered calcium-regulated affinity protein for efficient internalization and lysosomal toxin delivery.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 25, 2025
Deciphering the determinants of recombinant protein expression across the human secretome.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 07, 2025
A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.
Journal: Molecular therapy. Advances
Published: July 05, 2025
The many virtues of staphylococcal protein A: A journey from N to C terminus.
Journal: Journal of biotechnology
Published: February 27, 2025
Deep sequencing combined with high-throughput screening enables efficient development of a pH-dependent high-affinity binding domain targeting HER3.
Journal: Protein science : a publication of the Protein Society
Published: January 31, 2025
Immobilizing calcium-dependent affinity ligand onto iron oxide nanoparticles for mild magnetic mAb separation.
Journal: Biotechnology reports (Amsterdam, Netherlands)
Published: October 07, 2024
Cooperative folding as a molecular switch in an evolved antibody binder.
Journal: The Journal of biological chemistry
Published: July 06, 2024
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19.
Journal: Nature communications
Published: May 07, 2024
Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [99mTc]Tc-ADAPT6.
Journal: Pharmaceutics
Published: February 17, 2024
Fast and robust recombinant protein production utilizing episomal stable pools in WAVE bioreactors.
Journal: Protein expression and purification
Published: January 09, 2024
Targeted HER2-positive cancer therapy using ADAPT6 fused to horseradish peroxidase.
Journal: New biotechnology
Published: December 30, 2023
Last Updated: 09/26/2026